Eli Lilly Japan and Mitsubishi Tanabe Pharma Corporation signed a sales collaboration agreement in Japan for GIP/GLP-1 receptor agonist ¡°Tirzepatide¡±
July 7, 2022
Mitsubishi Tanabe Pharma Corporation, a member of the Ä¢¹½ÊÓÆµ, has announced the following press release.
¡öMitsubishi Tanabe Pharma¡¡Press Release
¡öMitsubishi Tanabe Pharma¡¡Press Release
Eli Lilly Japan and Mitsubishi Tanabe Pharma Corporation signed a sales collaboration agreement in Japan for GIP/GLP-1 receptor agonist “Tirzepatide”